7.60

19.87% 1.26

After Hours: 7.54 -0.06 -0.79%

Biodesix Inc (BDSX)

Overview News Price History Option Chain Financials Discussions Forecast

Biodesix Inc stock is traded at $7.60, with a volume of 235.57K. It is up +19.87% in the last 24 hours and down -1.81% over the past month. Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Previous Close:

$6.34

Open:

$7.06

24h Volume:

235.57K

Relative Volume:

1.17

Market Cap:

$50.72M

Revenue:

$49.09M

Net Income/Loss:

$-52.15M

P/E Ratio:

-11.69

EPS:

-0.65

Net Cash Flow:

$-45.93M

1W Performance:

+16.03%

1M Performance:

-1.81%

6M Performance:

-26.64%

1Y Performance:

-72.66%

1-Day Range:

$6.45

$7.79

1-Week Range:

$6.19

$7.79

52-Week Range:

$3.436

$32.20

Biodesix Inc Stock (BDSX) Company Profile

Name

Biodesix Inc

Sector

Healthcare (1135)

Industry

Diagnostics & Research (53)

Phone

303-417-0500

Address

919 WEST DILLON ROAD, LOUISVILLE

Employee

273

Twitter

Next Earnings Date

2025-10-31

Latest SEC Filings

BDSX's Discussions on Twitter

Compare BDSX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BDSX Biodesix Inc	7.60	50.72M	49.09M	-52.15M	-45.93M	-0.65
TMO Thermo Fisher Scientific Inc	565.24	212.23B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	213.83	151.20B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	722.12	57.84B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	146.08	41.02B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	210.96	36.42B	15.90B	1.28B	2.21B	7.2842

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy
May-13-24	Initiated	TD Cowen	Buy
May-03-24	Initiated	Lake Street	Buy
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-23-20	Initiated	BTIG Research	Buy
Nov-23-20	Initiated	Canaccord Genuity	Buy
Nov-23-20	Initiated	Morgan Stanley	Overweight
Nov-23-20	Initiated	William Blair	Outperform

View All

Biodesix Inc Stock (BDSX) Latest News

09:08 AM

Biodesix stock maintains Buy rating at Canaccord after strong Q3 results - Investing.com Australia

09:08 AM

04:38 AM

Top chart patterns to watch in Biodesix Inc.July 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com

04:38 AM

04:37 AM

Is Biodesix Inc. stock a defensive play in 2025July 2025 Reactions & High Accuracy Investment Signals - newser.com

04:37 AM

02:42 AM

Can Biodesix Inc. stock outperform in 2025 bull marketQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com

02:42 AM

01:26 AM

Technical signs of recovery in Biodesix Inc.Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com

01:26 AM

12:01 PM